AMAG Pharmaceuticals - 48 Year Dividend History | AMAG
Historical dividend payout and yield for AMAG Pharmaceuticals (AMAG) since 1971. The current TTM dividend payout for AMAG Pharmaceuticals (AMAG) as of September 20, 2019 is $0.00. The current dividend yield for AMAG Pharmaceuticals as of September 20, 2019 is 0.00%.
||Medical - Biomedical and Genetics
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease patients.Combidex?, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging to aid in the differentiation of cancerous from normal lymph nodes. In March 2005, the company received an approvable letter from the FDA with respect to Combidex, subject to certain conditions.